94 related articles for article (PubMed ID: 24278174)
1. Enterocyte proliferation and signaling are constitutively altered in celiac disease.
Nanayakkara M; Lania G; Maglio M; Kosova R; Sarno M; Gaito A; Discepolo V; Troncone R; Auricchio S; Auricchio R; Barone MV
PLoS One; 2013; 8(10):e76006. PubMed ID: 24204586
[TBL] [Abstract][Full Text] [Related]
2. Gliadin-mediated proliferation and innate immune activation in celiac disease are due to alterations in vesicular trafficking.
Barone MV; Zanzi D; Maglio M; Nanayakkara M; Santagata S; Lania G; Miele E; Ribecco MT; Maurano F; Auricchio R; Gianfrani C; Ferrini S; Troncone R; Auricchio S
PLoS One; 2011 Feb; 6(2):e17039. PubMed ID: 21364874
[TBL] [Abstract][Full Text] [Related]
3. IL-10-producing regulatory cells impact on celiac disease evolution.
Passerini L; Amodio G; Bassi V; Vitale S; Mottola I; Di Stefano M; Fanti L; Sgaramella P; Ziparo C; Furio S; Auricchio R; Barera G; Di Nardo G; Troncone R; Gianfrani C; Gregori S
Clin Immunol; 2024 Mar; 260():109923. PubMed ID: 38316201
[TBL] [Abstract][Full Text] [Related]
4. A Cumulative Effect of Food and Viruses to Trigger Celiac Disease (CD): A Commentary on the Recent Literature.
Barone MV; Auricchio S
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670760
[TBL] [Abstract][Full Text] [Related]
5. The potential utility of tight junction regulation in celiac disease: focus on larazotide acetate.
Khaleghi S; Ju JM; Lamba A; Murray JA
Therap Adv Gastroenterol; 2016 Jan; 9(1):37-49. PubMed ID: 26770266
[TBL] [Abstract][Full Text] [Related]
6. Celiac Disease: Role of the Epithelial Barrier.
Schumann M; Siegmund B; Schulzke JD; Fromm M
Cell Mol Gastroenterol Hepatol; 2017 Mar; 3(2):150-162. PubMed ID: 28275682
[TBL] [Abstract][Full Text] [Related]
7. Transcription Factor Binding Site Enrichment Analysis in Co-Expression Modules in Celiac Disease.
Romero-Garmendia I; Garcia-Etxebarria K; Hernandez-Vargas H; Santin I; Jauregi-Miguel A; Plaza-Izurieta L; Cros MP; Legarda M; Irastorza I; Herceg Z; Fernandez-Jimenez N; Bilbao JR
Genes (Basel); 2018 May; 9(5):. PubMed ID: 29748492
[TBL] [Abstract][Full Text] [Related]
8. PTPRK, an EGFR Phosphatase, Is Decreased in CeD Biopsies and Intestinal Organoids.
Nanayakkara M; Bellomo C; Furone F; Maglio M; Marano A; Lania G; Porpora M; Nicoletti M; Auricchio S; Barone MV
Cells; 2022 Dec; 12(1):. PubMed ID: 36611909
[TBL] [Abstract][Full Text] [Related]
9. Pivotal Role of Inflammation in Celiac Disease.
Barone MV; Auricchio R; Nanayakkara M; Greco L; Troncone R; Auricchio S
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806180
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Celiac Disease Patients Show Alterations of Dendritic Cell Shape and Actin Rearrangement.
Discepolo V; Lania G; Ten Eikelder MLG; Nanayakkara M; Sepe L; Tufano R; Troncone R; Auricchio S; Auricchio R; Paolella G; Barone MV
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800150
[TBL] [Abstract][Full Text] [Related]
11. Interplay between Type 2 Transglutaminase (TG2), Gliadin Peptide 31-43 and Anti-TG2 Antibodies in Celiac Disease.
Martucciello S; Sposito S; Esposito C; Paolella G; Caputo I
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456177
[TBL] [Abstract][Full Text] [Related]
12. Constitutive Differential Features of Type 2 Transglutaminase in Cells Derived from Celiac Patients and from Healthy Subjects.
Paolella G; Nanayakkara M; Sposito S; Lepretti M; Auricchio S; Esposito C; Barone MV; Martucciello S; Caputo I
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32059410
[TBL] [Abstract][Full Text] [Related]
13. Constitutive alterations in vesicular trafficking increase the sensitivity of cells from celiac disease patients to gliadin.
Lania G; Nanayakkara M; Maglio M; Auricchio R; Porpora M; Conte M; De Matteis MA; Rizzo R; Luini A; Discepolo V; Troncone R; Auricchio S; Barone MV
Commun Biol; 2019; 2():190. PubMed ID: 31123714
[TBL] [Abstract][Full Text] [Related]
14. p31-43 Gliadin Peptide Forms Oligomers and Induces NLRP3 Inflammasome/Caspase 1- Dependent Mucosal Damage in Small Intestine.
Gómez Castro MF; Miculán E; Herrera MG; Ruera C; Perez F; Prieto ED; Barrera E; Pantano S; Carasi P; Chirdo FG
Front Immunol; 2019; 10():31. PubMed ID: 30761127
[TBL] [Abstract][Full Text] [Related]
15. Anti-type 2 transglutaminase antibodies as modulators of type 2 transglutaminase functions: a possible pathological role in celiac disease.
Martucciello S; Paolella G; Esposito C; Lepretti M; Caputo I
Cell Mol Life Sci; 2018 Nov; 75(22):4107-4124. PubMed ID: 30136165
[TBL] [Abstract][Full Text] [Related]
16. Differences of immune disorders between Alzheimer's disease and breast cancer based on transcriptional regulation.
Kong W; Mou X; Deng J; Di B; Zhong R; Wang S; Yang Y; Zeng W
PLoS One; 2017; 12(7):e0180337. PubMed ID: 28719625
[TBL] [Abstract][Full Text] [Related]
17. Association of LPP and TAGAP Polymorphisms with Celiac Disease Risk: A Meta-Analysis.
Huang SQ; Zhang N; Zhou ZX; Huang CC; Zeng CL; Xiao D; Guo CC; Han YJ; Ye XH; Ye XG; Ou ML; Zhang BH; Liu Y; Zeng EY; Yang G; Jing CX
Int J Environ Res Public Health; 2017 Feb; 14(2):. PubMed ID: 28208589
[No Abstract] [Full Text] [Related]
18. Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa.
Barone MV; Troncone R; Auricchio S
Int J Mol Sci; 2014 Nov; 15(11):20518-37. PubMed ID: 25387079
[TBL] [Abstract][Full Text] [Related]
19. A celiac cellular phenotype, with altered LPP sub-cellular distribution, is inducible in controls by the toxic gliadin peptide P31-43.
Nanayakkara M; Kosova R; Lania G; Sarno M; Gaito A; Galatola M; Greco L; Cuomo M; Troncone R; Auricchio S; Auricchio R; Barone MV
PLoS One; 2013; 8(11):e79763. PubMed ID: 24278174
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
